MUSK and myasthenia gravis: Together, these findings indicate that an agonist antibody to MuSK, ARGX-119, can halt or reverse severe symptoms of neuromuscular disease, caused by two different pathogenic antibodies derived from a MuSK MG patient, even when intervention with ARGX-119 began after disease onset in this mouse model of MuSK MG.